Shanghai Runda Medical Technology Co

Shanghai Runda Medical Technology Co Equity Growth

The Year-over-Year Equity Growth of Shanghai Runda Medical Technology Co (603108.SS) as of Nov 3, 2026 is -13.05 %. In the previous year, Year-over-Year Equity Growth was 1.74 % — a change of -850.19% (lower).

Equity Growth

-13.05 %

YoY

-850.19%

Last updated:

Year-over-Year Equity Growth of Shanghai Runda Medical Technology Co is 2025 -13.05 % . Year-over-Year Equity Growth of Shanghai Runda Medical Technology Co was 2024 1.74 % . It decreases by -850.19% lower compared to the previous year.

The Shanghai Runda Medical Technology Co Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
9.55 CNY
Jan 1, 2019
10.09 CNY
Jan 1, 2020
16.13 CNY
Jan 1, 2021
8.10 CNY
Jan 1, 2022
12.29 CNY
Jan 1, 2023
10.07 CNY
Jan 1, 2024
1.74 CNY
Jan 1, 2025
-13.05 CNY
The Shanghai Runda Medical Technology Co Equity Growth history
YEAREquity GrowthYoY
-13.05 %-850.19%
1.74 %-82.73%
10.07 %-18.06%
12.29 %+51.84%
8.10 %-49.81%
16.13 %+59.86%
10.09 %+5.62%
9.55 %+19.14%
8.02 %-93.79%
129.14 %+36.86%
94.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Runda Medical Technology Co Stock analysis

What does Shanghai Runda Medical Technology Co do? Shanghai Runda Medical Technology Co., Ltd. generates revenue through the wholesale distribution of surgical and medical instruments, apparatus, and equipment within the domestic market. The company offers integrated services including product portfolio options, professional application services, logistics warehousing distribution systems, and technical support. Its customers include healthcare providers and medical institutions that require surgical tools and equipment. The firm's business model focuses on domestic sales with a workforce of 3,499 full-time employees managing these operations. The company's primary revenue streams come from the distribution of medical instruments and equipment, supported by its comprehensive service offerings. It provides sales support and customer channel management to facilitate transactions with its clients. The firm's domestic market focus ensures that its services are tailored to the needs of Chinese healthcare facilities and institutions. Shanghai Runda's business is structured around the wholesale distribution of medical products, with additional value-added services such as technical support and logistics management. The company's integrated approach combines product distribution with application services, enhancing its market position in the domestic healthcare sector. Shanghai Runda Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Runda Medical Technology Co stock

Year-over-Year Equity Growth of Shanghai Runda Medical Technology Co is -13.05 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Shanghai Runda Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Shanghai Runda Medical Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Shanghai Runda Medical Technology Co

All Key Metrics — Shanghai Runda Medical Technology Co